Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Karen Dawes
Age : 69
Public asset : 24,225,492 USD
Country of residence : Unknown
Linked companies : Repligen Corporation - Vaccitech plc - Medicenna Therapeutics Corp. - PaxMedica, Inc.

Biography of Karen Dawes 
Ms. Karen T. Dawes is an Independent Director at Vaccitech (UK) Ltd., an Independent Director at PaxMedica, Inc., a Chairman at Repligen Corp. and a President at Knowledgeable Decisions LLC. She is on the Board of Directors at Vaccitech (UK) Ltd., PaxMedica, Inc., Medicenna Therapeutics Corp., Symbiomix Therapeutics LLC, Medicines 360, Seaside Therapeutics LLC and Vaccitech Plc. Ms. Dawes was previously employed as an Independent Director by Assertio Therapeutics, Inc., a Chairman by PDL BioPharma, Inc., a Senior Vice President & Head-US Business Group by Bayer Corp., a Senior Vice President by Wyeth Pharmaceuticals, Inc., a Chief Commercial Officer by Genetics Institute, Inc., a Vice President-Marketing by Pfizer Inc., and a Senior Vice President-Global Strategic Marketing by Wyeth Corp. She also served on the board at Inspiration Biopharmaceuticals, Inc., Protein Design Labs, Inc. and Genaissance Pharmaceuticals, Inc. She received her undergraduate degree from Simmons University, a graduate degree from Simmons University and an MBA from Harvard University.

Current positions of Karen Dawes 
Holdings of Karen Dawes 
Karen Dawes : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
01/17ELON MUSK : Top Energy News of the Day
More news

© 2022 People and Ownership :   
Karen Dawes : Connections 

Latest news about Karen Dawes 
2019Medicenna Therapeutics Corp. Appoints Karen Dawes as Director
More news